Powder: -20°C for 3 years
In solvent: -80°C for 2 years
GSK1838705A is an effective <a href="/target/IGF_1R" style="display: inline; color: #c13a36">IGF-1R</a> inhibitor (IC50: 2.0 nM), modestly potent to IR (IC50: 1.6 nM) and <a href="/target/ALK" style="display: inline; color: #c13a36">ALK</a> (IC50: 0.5 nM), respectively, and little inhibition to other protein kinases.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 54.00 | |
5 mg | In stock | $ 77.00 | |
10 mg | In stock | $ 134.00 | |
25 mg | In stock | $ 280.00 | |
50 mg | In stock | $ 506.00 | |
100 mg | In stock | $ 774.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 89.00 |
Description | GSK1838705A is an effective IGF-1R inhibitor (IC50: 2.0 nM), modestly potent to IR (IC50: 1.6 nM) and ALK (IC50: 0.5 nM), respectively, and little inhibition to other protein kinases. |
Targets&IC50 | ALK:0.5 nM, IGF-1R:2 nM, Insulin Receptor:1.6 nM |
Kinase Assay | Kinase Assays: Baculovirus-expressed glutathione S-transferase-tagged proteins encoding the intracellular domain of IGF-1R (amino acids 957-1367) and IR (amino acids 979-1382) are used for determinations of IC50s by a homogeneous time-resolved fluorescence assay. A filter binding assay is used for appKi determinations using activated IGF-1R and IR kinases. Expanded kinase-selectivity profiling of GSK1838705A is carried out by screening the compound in the KinaseProfiler panel. |
Cell Research | Cells are seeded in 96-well dishes, incubated overnight at 37 °C, and treated with DMSO or GSK1838705A for 72 hours. For the NIH-3T3/LISN proliferation assays, cells are seeded on collagen-coated 96-well tissue culture plates and allowed to adhere for 24 hours. The medium is replaced with serum-free medium and the cells are treated with GSK1838705A for 2 hour. Cells are incubated for 72 hours after addition of IGF-I (30 ng/mL). Cell proliferation is quantified using the CellTiter-Glo Luminescent Cell Viability Assay. IC50s are determined from cytotoxicity curves using a four-parameter curve fit software package (XLfit4(Only for Reference) |
Molecular Weight | 532.58 |
Formula | C27H29FN8O3 |
CAS No. | 1116235-97-2 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 53.3 mg/mL (100 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GSK1838705A 1116235-97-2 Angiogenesis MAPK PI3K/Akt/mTOR signaling Tyrosine Kinase/Adaptors IGF-1R JNK S6 Kinase ALK CD246 Anaplastic lymphoma kinase inhibit Cluster of differentiation 246 Anaplastic lymphoma kinase (ALK) ALK tyrosine kinase receptor GSK-1838705A Inhibitor Insulin Receptor inhibitor